<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>佰傲谷BioValley | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-10-29T20:18:11+08:00</updated>
  <subtitle>佰傲谷致力于打造一个垂直于生物制品领域的第三方平台。为生物制药企业提供品牌推广、技术咨询、项目交易、企业合作、人才培养等服务。为生物制药行业从业人员提供沟通交流、会议培训、工作求职、个人展示平台</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【佰家言】君实生物张宏：实现生物工艺4.0其实并不是南柯一梦</title>
    <updated>2020-10-29T17:11:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/n86LhbbaVF3Ubj9KlS2dIw</id>
    <link href="https://mp.weixin.qq.com/s/n86LhbbaVF3Ubj9KlS2dIw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>维立志博完成近2亿元人民币新一轮融资</title>
    <updated>2020-10-29T17:11:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/SNOIbGbQ9a945XsyJKsEDg</id>
    <link href="https://mp.weixin.qq.com/s/SNOIbGbQ9a945XsyJKsEDg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>佰傲谷推荐|2020第十期结晶工艺关键技术开发研究与设计培训班</title>
    <updated>2020-10-29T17:11:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/KdxX5xmBHP-L7XdxPWaMBw</id>
    <link href="https://mp.weixin.qq.com/s/KdxX5xmBHP-L7XdxPWaMBw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>集赞送票！1000+生物工艺科学家行业年会！12月4-5日即将超燃开启！</title>
    <updated>2020-10-29T17:11:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/Atu-4BV-Pi25DLpbHNVqQg</id>
    <link href="https://mp.weixin.qq.com/s/Atu-4BV-Pi25DLpbHNVqQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>招聘 | 博奥明赛 | 抗体研发负责人、科学家等</title>
    <updated>2020-10-29T17:11:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/nH5MKvdiKsPHdNCYae8tQA</id>
    <link href="https://mp.weixin.qq.com/s/nH5MKvdiKsPHdNCYae8tQA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“单药不理想，联用来救场？”阿斯利康与Revolution共同开发KRAS/SHP2联合疗法</title>
    <updated>2020-10-28T13:30:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/10n1iynT3wEyQWFcG4DfRQ</id>
    <link href="https://mp.weixin.qq.com/s/10n1iynT3wEyQWFcG4DfRQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>集赞送票，等你来抢！1000+生物工艺科学家行业年会！12月4-5日即将超燃开启！</title>
    <updated>2020-10-28T13:30:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/TX1hy4InSlTx_3MumYLQ-w</id>
    <link href="https://mp.weixin.qq.com/s/TX1hy4InSlTx_3MumYLQ-w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>再冲击科创版，抗艾第一股前沿生物今日上市</title>
    <updated>2020-10-28T13:30:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/MQqmN1-HjlyqXEmfD3ammA</id>
    <link href="https://mp.weixin.qq.com/s/MQqmN1-HjlyqXEmfD3ammA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>影响医药生物专利授权的难点及答复策略</title>
    <updated>2020-10-27T12:06:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-27:/s/DxqndewNc5BE1Jib61Ltrg</id>
    <link href="https://mp.weixin.qq.com/s/DxqndewNc5BE1Jib61Ltrg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>130张超50元京东卡等你来！人源化小鼠市场调研</title>
    <updated>2020-10-27T12:06:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-27:/s/kSj5CpttbZpuUuZKWq6PlQ</id>
    <link href="https://mp.weixin.qq.com/s/kSj5CpttbZpuUuZKWq6PlQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>加速基因疗法发展，拜耳拟斥资40亿美元收购新兴生物制药公司AskBio</title>
    <updated>2020-10-27T12:06:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-27:/s/2bxpIxhZgndYmdpPkZnPvg</id>
    <link href="https://mp.weixin.qq.com/s/2bxpIxhZgndYmdpPkZnPvg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>人源化小鼠助力明星靶点，PD-1/PD-L1肿瘤微环境评估模型建立</title>
    <updated>2020-10-26T11:43:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/EkMTcgvnEyVPqFxoVTOkSw</id>
    <link href="https://mp.weixin.qq.com/s/EkMTcgvnEyVPqFxoVTOkSw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>缓解近似进展：低剂量阿托品研发进展</title>
    <updated>2020-10-26T11:43:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/XvAqLYJs5aK0wOF2JN-6ow</id>
    <link href="https://mp.weixin.qq.com/s/XvAqLYJs5aK0wOF2JN-6ow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【权威领衔，众咖云集】12月不可错过的生物药新型工艺开发及应用高峰论坛，你一定要来！</title>
    <updated>2020-10-26T11:43:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/yEV_Ly40soVWzurkiuN50w</id>
    <link href="https://mp.weixin.qq.com/s/yEV_Ly40soVWzurkiuN50w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>详解生物制药行业年度最具收购价值top10</title>
    <updated>2020-10-25T10:58:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-25:/s/8K5l--CdLnfwfoG-LY82yQ</id>
    <link href="https://mp.weixin.qq.com/s/8K5l--CdLnfwfoG-LY82yQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>渤健终止靶向LINGO-1抗体Opicinumab和SMN1基因疗法BIIB089的研发</title>
    <updated>2020-10-25T10:58:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-25:/s/QYBRAscMvvKum1vjF_wG1A</id>
    <link href="https://mp.weixin.qq.com/s/QYBRAscMvvKum1vjF_wG1A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【权威领衔，众咖云集】12月不可错过的生物药新型工艺开发及应用高峰论坛，你一定要来！</title>
    <updated>2020-10-25T10:58:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-25:/s/THFn1UxhvtMU2QMbZAIZ_g</id>
    <link href="https://mp.weixin.qq.com/s/THFn1UxhvtMU2QMbZAIZ_g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>千人盛会，圆满闭幕！Bio-Autumn生物药质量法规&amp;分析科学论坛精彩回顾</title>
    <updated>2020-10-24T12:42:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-24:/s/OOs2cmcpjFo8qemKrzDvag</id>
    <link href="https://mp.weixin.qq.com/s/OOs2cmcpjFo8qemKrzDvag" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>诺华口服SMA药物另辟蹊径开发亨廷顿病</title>
    <updated>2020-10-24T12:42:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-24:/s/gMZ2MBPRSC3vNDuD_FiTBw</id>
    <link href="https://mp.weixin.qq.com/s/gMZ2MBPRSC3vNDuD_FiTBw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>靶点药讯32|纵览全球药物靶点动态</title>
    <updated>2020-10-24T12:42:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-24:/s/hm7ZOGqjw3yTGvPi6sBHog</id>
    <link href="https://mp.weixin.qq.com/s/hm7ZOGqjw3yTGvPi6sBHog" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>